Stephen Knight joined F-Prime Capital in 2003 where he serves as President and Managing Partner. He has worked in the pharmaceutical and biotechnology industries for over 25 years and invests broadly across healthcare. Steve serves on the Board of Directors of Beam Therapeutics, Genomics plc, Iora Health, Pulmocide, Sana Biotechnology, and SemmaTherapeutics. Prior to joining F-Prime Capital, Steve held various senior management roles in private and public biotechnology and consulting companies. He also was a researcher at AT&T Bell Laboratories, the National Institutes of Health, and Yale University. He holds an M.D. from the Yale University School of Medicine, an M.B.A. from the Yale School of Organization and Management and received a B.S. in biology from Columbia University, graduating summa cum laude and Phi Beta Kappa.
Location
Cambridge, Massachusetts
Notable investments
No items found.
Check size range(s)
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Series B+
Rounds their fund leads
Seed
Series A
Sectors their fund invests in
Biotech
Health
Enterprise
Fintech
Deeptech
Geographies their fund invests in
USA
Europe
Asia-Pacific
![](https://cdn.prod.website-files.com/62f3f3ccd0cfd515f3b095e4/6601d814595d501c6adfa00a_Harmonic%20AI.jpg)
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
F-Prime Capital (fka Fidelity Biosciences)
About the Fund
Invests in healthcare and technology in the US and Europe Funded in 1946 and have over $2T in assets managed.
View Profile
Their Colleagues
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets